ARTICLE | Clinical News
Hyal regulatory update
January 9, 1995 8:00 AM UTC
HYALF filed for U.S. marketing approval of Hyanalgese-D, a proprietary formulation of the non-steroidal anti-inflammatory drug diclofenac, for the treatment of pain associated with osteoarthritis. The...